Neuronetics (STIM) Cash from Financing Activities (2017 - 2026)
Neuronetics (STIM) posted quarterly Cash from Financing Activities of -$5.6 million for Q1 2026, down 129.39% year-over-year from $19.0 million in Q1 2025, and down 441.98% quarter-over-quarter from -$1.0 million in Q4 2025.
Neuronetics (STIM) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Cash from Financing Activities for 10 consecutive years, with -$5.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 129.39% year-over-year to -$5.6 million; the TTM figure through Mar 2026 stood at $11.3 million (down 77.76% YoY), while the FY2025 annual figure was $35.8 million, up 626.59% from the prior year.
- Cash from Financing Activities fell to -$5.6 million in Q1 2026 per STIM's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $22.3 million in Q4 2023 and bottomed at -$5.6 million in Q1 2026.
- Historically, Cash from Financing Activities has averaged $5.2 million across 5 years, with a median of $127500.0 in 2022.
- On a YoY basis, Cash from Financing Activities climbed as much as 8985.71% in 2023 and fell as far as 720.0% in 2023.
- Neuronetics' Cash from Financing Activities stood at $245000.0 in 2022, then jumped by 8985.71% to $22.3 million in 2023, then sank by 57.04% to $9.6 million in 2024, then tumbled by 110.76% to -$1.0 million in 2025, then tumbled by 441.98% to -$5.6 million in 2026.
- Business Quant data shows STIM's Cash from Financing Activities at -$5.6 million in Q1 2026, -$1.0 million in Q4 2025, and $17.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Neuronetics | 225.97 Mn | 206.54 Mn | 21.22 Mn | 7.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.41 Mn |
| Jun 30, 2026 | 7.41 Mn |
| Mar 31, 2026 | -5.58 Mn |
| Mar 31, 2026 | -5.58 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | 17.90 Mn |
| Sep 30, 2025 | 17.90 Mn |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 18.98 Mn |
| Mar 31, 2025 | 18.98 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Dec 31, 2023 | 22.26 Mn |
| Dec 31, 2023 | 22.26 Mn |
| Jun 30, 2023 | -62,000.00 |
| Jun 30, 2023 | -62,000.00 |
| Mar 31, 2023 | 499,000.00 |
| Mar 31, 2023 | 499,000.00 |